Stay updated on CC-486 and MK-3475 in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the CC-486 and MK-3475 in Lung Cancer Clinical Trial page.

Latest updates to the CC-486 and MK-3475 in Lung Cancer Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.0%
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe web page has undergone significant changes, including the removal of detailed study descriptions and inclusion criteria for a clinical trial involving CC-486 and pembrolizumab for non-small cell lung cancer. Additionally, the revision number has been updated from v2.14.4 to v2.15.0.SummaryDifference39%
- Check30 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from March 25, 2025, to March 18, 2025.SummaryDifference0.1%
- Check37 days agoChange DetectedThe page has been updated to reflect a new version (v2.14.3) and a more recent last update date of March 25, 2025, replacing the previous version (v2.14.2) and date of March 18, 2025.SummaryDifference0.1%
- Check44 days agoChange DetectedThe page has updated its status to 'Active, not recruiting' and added several important dates related to the trial, while removing outdated information and references to previous statuses and institutions.SummaryDifference1%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference0.7%
Stay in the know with updates to CC-486 and MK-3475 in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CC-486 and MK-3475 in Lung Cancer Clinical Trial page.